Carter Denise P. 4
4 · Quoin Pharmaceuticals, Ltd. · Filed Jun 2, 2025
Insider Transaction Report
Form 4
Carter Denise P.
DirectorChief Operating Officer
Transactions
- Award
Share Option (Right to Buy)
2025-05-29+42,039→ 42,039 totalExercise: $9.07Exp: 2035-05-29→ ADS (42,039 underlying)
Footnotes (2)
- [F1]The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"). Each ADS represents thirty-five ordinary shares of the Issuer.
- [F2]The option vests in four annual installments with 20% vesting on each of May 29, 2026, 2027 and 2028 and 40% vesting on May 29, 2029.